Predicting early spread of cervical cancer after radiation
Part of Cancer, Women’s health & pregnancy clinical trials.
This study creates a model to predict if cervical cancer will spread early after radiation therapy. It looks at medical records to help doctors better understand who is at higher risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with cervical cancer through a biopsy.
- You must have had radiation therapy (not surgery) as your main treatment.
- Your cancer must not have spread within 3 months after radiation.
- You must have complete medical records before starting treatment and for at least 1 year after radiation.
- You cannot have had any other cancer in the past.
- You must have finished your full course of radiation therapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses MRI scans taken before treatment to predict survival in women getting radiation therapy for cervical cancer. It helps doctors understand which patients may do better and guide future care.
This trial tests a feasibility (“can it be done safely?”) approach that delivers radiation in a shorter schedule for some cervical cancer patients. It also uses weekly cisplatin chemotherapy and includes a radiation procedure called brachytherapy to improve treatment effectiveness.
This study tests a new way to plan a type of radiation called brachytherapy for advanced cervical cancer. It uses virtual images to see if this method can treat the tumor just as well while being safer.
This trial studies giving radiation after surgery for certain early-stage uterine (endometrial) cancer types. It may help lower the chance the cancer comes back, especially for higher-grade cases.
This study looks at how cervical cancer and radiation therapy affect the body. It aims to understand why side effects happen, which could lead to better treatment in the future.
This trial tests a special type of radiation that is given in small, spaced-out beams to treat gynecologic cancers (like cervical or uterine cancer). It is for patients who cannot get standard internal radiation (brachytherapy) because of unusual anatomy, large tumors, a narrow vagina, or anesthesia risks.
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.